Awarded to
- Awarded value
- €664,225
- Bids received
- 132 over 35 lots
- Record with this buyer
- 3 contracts from this buyer in the register, €7.8M in total
Description
35 lots
- Lot 1
- Combinatii Bictegravirum+ Emtricitabinum+ Tenofovirum 50mg/ 200mg/ 25mg compr filmate estimated €2,975,634 · 36 months · Antivirals for systemic use
- Lot 2
- Acidum clodronicum 300 mg/ 5 ml conc pt sol perf flacon estimated €2,724 · 36 months
- Lot 3
- Acidum zoledronicum 4mg/ 5ml conc pt sol perf flacon estimated €21,366 · 36 months
- Lot 4
- Acidum zoledronicum 4mg/ 100 ml conc pt sol perf flacon estimated €7,103 · 36 months
- Lot 5
- Bevacizumabum 25 mg/ ml-16 ml concentrat (400mg) conc.pt.sol perf flacon estimated €448,527 · 36 months
- Lot 6
- Bevacizumabum 25 mg/ ml- 4 ml concentrat (100mg) conc pt sol perf flacon estimated €77,670 · 36 months
- Lot 7
- Carboplatinum 10mg/ml - 15 ml concentrat (150mg) conc.pt.sol perf flacon estimated €19,795 · 36 months
- Lot 8
- Carboplatinum 10mg/ml - 45 ml concentrat (450mg) conc pt sol perf flacon estimated €72,959 · 36 months
- How tenders are scored
- Pretul ofertei; Termen de furnizare The lots are scored differently: the official notice gives each lot its own criteria.
Show 27 more lots
- Lot 9
- Docetaxelum 20mg/ml conc.pt.sol perf flacon 1 ml ce contine 20 mg docetaxel estimated €9,340 · 36 months
- Lot 10
- Docetaxelum 80mg/4ml conc pt sol perf flacon 4 ml ce contine 80 mg docetaxel estimated €27,193 · 36 months
- Lot 11
- Epirubicinum 2mg/ml - 50 ml sol.inj.x100mg (100mg/ 50ml) sol inj./perf flacon estimated €14,138 · 36 months
- Lot 12
- Filgrastimum 30MU/ 0,5 ml sol.inj/ perf seringa preumpluta estimated €40,789 · 36 months
- Lot 13
- Filgrastimum 48MU/ 0,5 ml sol.inj/ perf seringa preumpluta estimated €39,558 · 36 months
- Lot 14
- Fludarabinum 25mg/ml-5ml cu pulb.pt.sol. continand 50mg fludarabina pulb.pt. sol.inj./ perf flacon estimated €9,768 · 36 months
- Lot 15
- Fluorouracilum 50mg/ml- 20 ml concentrat-conc.pt.sol. inj/ perf.-flacon estimated €8,772 · 36 months
- Lot 16
- Gemcitabinum 100mg/ml x10m conc.pt.sol perfl flacon estimated €5,866 · 36 months
- Lot 17
- Gemcitabinum 38mg/mlxm -5,26 ml conc. pt.sol.perf. care contine 200mg gemcitabina conc.pt.sol perf flacon estimated €19,098 · 36 months
- Lot 18
- Gemcitabinum 38mg/mlxm -5,26 ml conc. pt.sol.perf. care contine 200mg gemcitabina conc.pt.sol perf flacon estimated €56,313 · 36 months
- Lot 19
- Gemcitabinum 38mg/mlxm -52,6 ml conc. pt.sol.perf. care contine 2000mg gemcitabina conc.pt.sol perf flacon estimated €28,494 · 36 months
- Lot 20
- Irinotecanum 20mg/ml- 5ml conc.pt. sol conc.pt.sol perf flacon estimated €10,258 · 36 months
- Lot 21
- Irinotecanum 20mg/ml-15 ml conc.pt. sol conc.pt.sol perf flacon estimated €33,738 · 36 months
- Lot 22
- Mitoxantronum 2mg/ml-10ml concentrat conc.pt.sol inj. flacon estimated €36,894 · 36 months
- Lot 23
- Obinutuzumabum 1000 mg -flac de 50ml care contine 40 ml conc -conc.pt. sol conc.pt.sol perf flacon estimated €1,078,677 · 36 months
- Lot 24
- Oxaliplatinum 5mg/ml -50 mg conc.pt.sol perf flacon estimated €13,256 · 36 months
- Lot 25
- Oxaliplatinum 5mg/ml -100 mg -conc.pt. sol conc.pt.sol perf flacon estimated €24,342 · 36 months
- Lot 26
- Paclitaxelum 6mg/ml-30mg conc- conc.pt.sol perf flacon estimated €16,320 · 36 months
- Lot 27
- Paclitaxelum 6mg/ml-150mg conc-conc.pt. sol conc.pt.sol perf flacon estimated €51,070 · 36 months
- Lot 28
- Polatuzumab vedotin 20mg/ml - flacon ce contine 30 mg polatuzumab vedotin- pulb.pt. conc.pt sol. perf. flacon estimated €252,753 · 36 months
- Lot 29
- Polatuzumab vedotin 20mg/ml - flacon ce contine 140 mg polatuzumab vedotin -pulb.pt. conc.pt sol. perf flacon estimated €588,272 · 36 months
- Lot 30
- Rituximabum 10mg/ ml- 500mg -conc.pt sol. perf. flacon estimated €196,245 · 36 months
- Lot 31
- Rituximabum 10mg/ ml- 100mg -conc.pt sol. perf flacon estimated €78,705 · 36 months
- Lot 32
- Trastuzumabum 150mg- pulb pt conc.pt.sol perf - flacon estimated €179,372 · 36 months
- Lot 33
- Vincristinum 1mg/ml-conc.pt sol. perf flacon estimated €6,467 · 36 months
- Lot 34
- Cladribinum 2mg/ ml sol inj- flacon estimated €184,671 · 36 months
- Lot 35
- Brentuximab vedotin 50mg- pulb. pt.conc.pt sol. perf flacon estimated €236,747 · 36 months
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 4 hours ago
What this buyer has paid before
Based on 168 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €664,225
- Estimated value
- €6.9M
- Median award
- €296,662
- Middle half of past awards
- €126,719 to €609,689
The award is larger than three in four past awards.
Most recent awards
- România - Antivirale pentru uz sistemic - ACORD CADRU FURNIZARE MEDICAMENTE PROGRAME NATIONALE 4 €192,383
- România - Produse farmaceutice - Acord cadru furnizare medicamente Programe Nationale 7 €682,714
- România - Produse farmaceutice - Acord cadru furnizare medicamente PN 9 €308,008
- România - Antineoplazice - ACORD CADRU furnizare medicamente PROGRAME NATIONALE €4,624,037
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileSPITALUL JUDETEAN DE URGENTA RESITA
- notices in the register
- 199
- awards
- 187
- awarded in total
- €129.7M
Who wins its contracts
Many suppliers- different companies won its awards
- 88
- of the awards went to the three most frequent winners
- 19%
- of its calls state an estimated value
- 33%
Based on 186 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.7
- of those lots received a single tender
- 27%
- of the awards went to companies based in another country
- 0%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Awards most often to
Market context
- open now in Medical equipment & pharmaceuticals
- 8,246
- median open notice
- €303,085
Who wins in this market
Many suppliersRomania · Medical equipment & pharmaceuticals
- different companies won awards here
- 6,914
- of the awards went to the three most frequent winners
- 2%
- buyers awarded contracts here
- 483
Based on 10,101 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.2
- of those lots received a single tender
- 28%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 4%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
8
days left
€1,751,485
est. value
18
days left
€2,000,983
est. value
19
days left
€3,887,969
est. value
4
days left
€7,845,987
est. value
Awarded before
Never miss a tender like this
249 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Antineoplastic agents: an email when new tenders arrive under it, no account needed.